Search

everythinglearnresearchcommunity

for

Search:↓

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

TRPV4 slows hair growth by affecting hair follicle cells.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Finasteride helps reduce pain and inflammation in animals.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Stress and certain chemicals affect hair growth by interacting with the immune and nervous systems.

Early changes in brain chemicals affect how a drug reduces alcohol intake in rats.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

4-Aminopyridine improves skin wound healing and tissue regeneration by increasing cell growth and promoting nerve repair.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Two patients with stubborn hair loss grew hair after PDRN injections.

Ruxolitinib cream may help treat severe hair loss in children.